• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by VSee Health Inc.

    12/4/25 4:46:03 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care
    Get the next $VSEE alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)


    VSEE HEALTH, INC.

    (Name of Issuer)


    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)


    92919Y102

    (CUSIP Number)


    Lawrence Sands
    c/o Digital Health Sponsor, LLC, 980 N. Federal Highway, #304
    Boca Raton, FL, 33432
    561-672-7068

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    07/21/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    92919Y102


    1 Name of reporting person

    LAWRENCE SANDS
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    961,500.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    961,500.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    961,500.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    2.9 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    (1) Consists of: (i) 500,000 shares of common stock of the Issuer and 765 shares of Series A preferred stock convertible into 382,500 shares of the Issuer held by SCS Capital Partners LLC; and (ii) 2,500 shares of common stock of the Issuer and 153 shares of Series A preferred stock convertible into 76,500 shares of common stock of the Issuer held by SCS, LLC. Mr. Sands is the sole manager and sole member of each of SCS Capital Partners LLC and SCS, LLC.


    SCHEDULE 13D

    CUSIP No.
    92919Y102


    1 Name of reporting person

    DIGITAL HEALTH SPONSOR, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    0.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0.0 %
    14Type of Reporting Person (See Instructions)

    OO



    SCHEDULE 13D

    CUSIP No.
    92919Y102


    1 Name of reporting person

    SCS CAPITAL PARTNERS, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    882,500.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    882,500.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    882,500.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    2.7 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    (2) Consists of 500,000 shares of common stock of the Issuer and 765 shares of Series A preferred stock convertible into 382,500 shares of the Issuer held by SCS Capital Partners, LLC.


    SCHEDULE 13D

    CUSIP No.
    92919Y102


    1 Name of reporting person

    SCS, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    FLORIDA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    79,000.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    79,000.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    79,000.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0.2 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    (3) Consists of 2,500 shares of common stock of the Issuer and 153 shares of Series A preferred stock convertible into 76,500 shares of common stock of the Issuer held by SCS, LLC.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Common Stock, par value $0.0001 per share
    (b)Name of Issuer:

    VSEE HEALTH, INC.
    (c)Address of Issuer's Principal Executive Offices:

    980 N. Federal Highway, #304, Boca Raton, FLORIDA , 33432.
    Item 1 Comment:
    This Amendment No. 1 to Schedule 13D (this "Amendment") is being filed by Digital Health Sponsor, LLC, SCS Capital Management, LLC, SCS, LLC and Lawrence M. Sands (each of the foregoing, individually, a "Reporting Person", and collectively, the "Reporting Persons") with respect to the beneficial ownership of the Reporting Persons in VSee Health, Inc. a Delaware corporation (the "Issuer"). This Amendment is being filed to supplement and update the information set forth in the Schedule 13D as previously filed on July 1, 2024 (the "Original Schedule 13D"). Each Item included in this Amendment amends and restates the information disclosed in the corresponding Item of the Original Schedule 13D. Unless otherwise indicated herein, capitalized terms used but not defined in this Amendment shall have the same meanings herein as are ascribed to such terms in the Original Schedule 13D.
    Item 2.Identity and Background
    (a)
    Names of reporting persons: Lawrence M. Sands, Digital Health Sponsor, LLC, SCS Capital Partners, LLC, and SCS, LLC.
    (b)
    Residence or business address: 980 N. Federal Highway, #304, Boca Raton, FL 33432
    (c)
    Present principal occupation or employment and name, principal business and address of any corporation or other organization in which such employment is conducted: Lawrence Sands is the sole manager of Digital Health Sponsor LLC, and the sole member and sole manager of each of SCS Capital Partners, LLC and SCS, LLC. The principal address of each of the foregoing is 980 N. Federal Highway, #304, Boca Raton, FL 33432.
    (d)
    The reporting persons have not, during the last five years been convicted in a criminal proceeding (excluding traffic violation or similar misdemeanors)
    (e)
    The reporting person have not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction pursuant to which the reporting person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
    (f)
    Citizenship: Mr. Sands is a citizen of the United States of America. Each of Digital Health Sponsor, LLC and SCS Capital Partners, LLC is a Delaware limited liability company. SCS, LLC is a Florida limited liability company.
    Item 5.Interest in Securities of the Issuer
    (a)
    Aggregate number and percentage of class beneficially owned: Series A Aggregate No. Series A Preferred as Shares of Common Preferred converted to Warrant Common Percentage Stock Stock Common Stock Shares Stock of Class (1) Lawrence Sands 502,000 918 459,000 0 961,000 2.9% Digital Health Sponsor, LLC 0 0 0 0 0 0.0% SCS Capital Partners, LLC 500,000 765 382,500 0 882,500 2.7% SCS, LLC 2,500 153 76,500 0 79,000 0.2% (1) Based on 32,289,750 shares of common stock issued and outstanding as of December 2, 2025.
    (b)
    All of the shares of common stock reported in this Amendment are held directly by SCS Capital Partners, LLC or SCS, LLC. Lawrence M. Sands, in his capacity as the sole member and the sole manager of each of SCS Capital Partners, LLC and SCS, LLC, has sole voting and investment power with respect to the shares reported herein that are held by such entities.
    (c)
    On July 21, 2025, Digital Health Sponsor, LLC distributed 2,073,250 shares of the common stock of the Issuer to its members on a pro rata basis for no consideration. On October 28, 2025, Digital Health Sponsor, LLC distributed warrants to purchase up to 557,000 shares of the common stock of the Issuer to its members on a pro rata basis for no consideration. On November 6, 2025, Digital Health Sponsor, LLC distributed 557,000 shares of the common stock of the Issuer to its members on a pro rata basis for no consideration. On November 7, 2025, Digital Health Sponsor, LLC distributed 350 shares of the Series A preferred stock of the Issuer to its members on a pro rata basis for no consideration.
    (d)
    Not applicable.
    (e)
    Not applicable.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    LAWRENCE SANDS
     
    Signature:/s/ Lawrence M. Sands
    Name/Title:Lawrence M. Sands
    Date:12/04/2025
     
    DIGITAL HEALTH SPONSOR, LLC
     
    Signature:/s/ Lawrence M. Sands
    Name/Title:Lawrence M. Sands/Manager
    Date:12/04/2025
     
    SCS CAPITAL PARTNERS, LLC
     
    Signature:/s/ Lawrence M. Sands
    Name/Title:Lawrence M. Sands/Manager
    Date:12/04/2025
     
    SCS, LLC
     
    Signature:/s/ Lawrence M. Sands
    Name/Title:Lawrence M. Sands/Manager
    Date:12/04/2025
    Get the next $VSEE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSEE

    DatePrice TargetRatingAnalyst
    2/24/2025$5.00Buy
    Maxim Group
    More analyst ratings

    $VSEE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of secure digital health solutions, today announced the launch of its new AI doctor notes, one of the solutions in its AI solutions suite. VSee has partnered with Tele911, the largest national telemedicine emergency room diversion service, to integrate VSee's AI Doctor Notes into its virtual emergency care workflow. Emergency medicine demands rapid decision-making and high patient throughput. The integration has drastically reduced Tele911 physician's charting time by 93% from 15 minutes per visit to under 1 minute, potentially increasing physician visit capacity. This new VSee AI solution automatically transcribes visits and generates

    7/14/25 8:17:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions. The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke re

    6/23/25 8:27:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

    VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market.

    5/30/25 4:07:00 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    SEC Filings

    View All

    VSee Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - VSEE HEALTH, INC. (0001864531) (Filer)

    12/12/25 4:31:15 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - VSEE HEALTH, INC. (0001864531) (Filer)

    12/11/25 5:30:58 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Amendment: VSee Health Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K/A - VSEE HEALTH, INC. (0001864531) (Filer)

    12/11/25 3:17:12 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Digital Health Sponsor Llc disposed of 2,630,250 shares (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    12/4/25 6:27:27 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Co-CEO Aisiku Imoigele disposed of 120,000 shares, decreasing direct ownership by 3% to 3,416,990 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    11/19/24 8:57:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Large owner Sands Lawrence M. acquired $405,000 worth of shares (202,500 units at $2.00) (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    11/19/24 8:55:08 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on VSee Lab with a new price target

    Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00

    2/24/25 8:42:03 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Financials

    Live finance-specific insights

    View All

    VSee Health Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth

    12/20/24 9:00:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so

    12/2/24 4:05:00 PM ET
    $SXTP
    $VSEE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services

    $VSEE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 8:45:14 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 5:23:34 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by VSee Health Inc.

    SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)

    7/5/24 4:29:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care